Bacchus Vascular

Name

Bacchus Vascular

Website

https://bacchus-vascular.com

Company type

Private

Founded year

1999

Headcount range

251–500 employees

Short description

Bacchus Vascular is a Santa Clara-based medical device company founded in 1999 that develops therapeutic devices for interventional radiologists and vascular surgeons treating occlusive vascular disease.

Ownership category

akta.pro rank

Product category

Vascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

akta.pro secondary industries

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK), Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)

Keywords

• Vascular medical devices
• Interventional radiology devices
• Occlusive vascular therapy
• Thrombectomy devices
• Minimally invasive vascular

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Core offering

Bacchus Vascular designs, develops, and sells therapeutic medical devices used by interventional radiologists and vascular surgeons to treat occlusive vascular disease. The company's portfolio addresses minimally invasive interventions for blood vessel blockages, supporting clinical procedures performed in hospital and specialty care settings.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Surmodics: Surmodics develops surface coating technologies and drug-coated balloon catheters for peripheral vascular interventions, addressing the same occlusive vascular disease patient population that Bacchus Vascular's therapeutic devices serve.

Broad incumbents

• Terumo Interventional Systems: Terumo offers a broad portfolio of interventional vascular access and therapeutic devices for peripheral vascular disease. While a broader incumbent, its products in the occlusive vascular disease space compete with Bacchus Vascular's portfolio in the same hospital and specialty call points.
• Abbott Vascular: Abbott's vascular division offers a broad portfolio of peripheral and coronary interventional devices, including devices used to treat occlusive vascular disease. As a major incumbent, it competes for interventional radiology and vascular surgery mindshare and procedure volumes alongside Bacchus Vascular's therapeutic offerings.
• Boston Scientific: Boston Scientific is a large diversified medical device company with a substantial peripheral interventions franchise addressing vascular occlusive disease. While broader in scope than Bacchus Vascular, its peripheral vascular products compete in the same call point and overlap on therapeutic device categories.

Direct peers

• Cardiovascular Systems (Abbott): Cardiovascular Systems, now part of Abbott, developed atherectomy devices for peripheral arterial disease — a therapeutic device category directly adjacent to Bacchus Vascular's occlusive vascular disease portfolio, serving the same vascular surgeon and interventional radiologist customers.
• Penumbra: Penumbra is a leading developer of thrombectomy and aspiration devices for peripheral and neurovascular occlusive disease, directly competing with Bacchus Vascular's core therapeutic device portfolio. Its Indigo aspiration system and dedicated peripheral thrombectomy franchise overlap heavily with the interventional radiology and vascular surgery call point.
• Argon Medical Devices: Argon Medical manufactures a portfolio of vascular intervention devices including thrombectomy, biopsy, and drainage products, directly competing with Bacchus Vascular in the interventional radiology call point and on therapeutic vascular devices.
• AngioDynamics: AngioDynamics manufactures peripheral vascular and thrombectomy devices used by interventional radiologists and vascular surgeons, including the AngioJet system — a direct competitor and at times predecessor asset relative to Bacchus Vascular's offerings in the occlusive vascular disease space.
• Inari Medical: Inari Medical specializes in mechanical thrombectomy devices for venous thromboembolism and peripheral arterial disease, directly serving the same interventional radiology and vascular surgery customers that Bacchus Vascular targets with its therapeutic devices.

Others

• Medtronic: Medtronic is the apparent acquirer of Bacchus Vascular (per the Medtronic URL present in source data) and operates a major peripheral and cardiovascular intervention franchise. It is included as a peer because it now controls the asset, and its broader peripheral vascular portfolio overlaps with the therapeutic device category Bacchus Vascular originally addressed.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bacchus Vascular